Literature DB >> 2023864

Synthesis and in vitro receptor binding studies of fluorotamoxifen analogues.

D J Yang1, S Wallace, W Tansey, K C Wright, L R Kuang, R S Tilbury, I Diego, J L Lim, A M Emran, E E Kim.   

Abstract

We describe the synthesis of new fluorotamoxifen analogues with the fluorine atom positioned on the end of the aliphatic chain of tamoxifen. The binding of fluorotamoxifens to cytosol estrogen receptors of rat uteri was determined with [3H]estradiol (5 nM). The fluorotamoxifens had similar or superior binding affinities compared with tamoxifen. The IC50 value was as follows: tamoxifen, 5 x 10(-7) M; fluorotamoxifen (VII), 5 x 10(-7) M; N,N-diethylfluorotamoxifen (IV)-cis, 1 x 10(-6) M, and trans, 2 x 10(-7) M; and (cis) fluoromethyl-N,N-diethyltamoxifen (VI) 1 x 10(-7) M. Therefore, the fluorinated tamoxifens have potential use in imaging estrogen receptors by PET.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2023864     DOI: 10.1023/a:1015879717742

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  A new triphenylethylene compound, Fc-1157a. I. Hormonal effects.

Authors:  S Kallio; L Kangas; G Blanco; R Johansson; A Karjalainen; M Perilä; I Pippo; H Sundquist; M Södervall; R Toivola
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  Breast cancer: PET imaging of estrogen receptors.

Authors:  M A Mintun; M J Welch; B A Siegel; C J Mathias; J W Brodack; A H McGuire; J A Katzenellenbogen
Journal:  Radiology       Date:  1988-10       Impact factor: 11.105

4.  Hydroxy derivatives of tamoxifen.

Authors:  A B Foster; M Jarman; O T Leung; R McCague; G Leclercq; N Devleeschouwer
Journal:  J Med Chem       Date:  1985-10       Impact factor: 7.446

5.  Stabilization of estradiol-receptor complexes by elimination of cytosolic factors.

Authors:  J H Fishman
Journal:  Biochem Biophys Res Commun       Date:  1983-02-10       Impact factor: 3.575

6.  NMDA receptor channels: labeling of MK-801 with iodine-125 and fluorine-18.

Authors:  D M Wieland; M R Kilbourn; D J Yang; E Laborde; D L Gildersleeve; M E Van Dort; J L Pirat; B J Ciliax; A B Young
Journal:  Int J Rad Appl Instrum A       Date:  1988

7.  Synthesis and receptor-binding affinity of fluorotamoxifen, a possible estrogen-receptor imaging agent.

Authors:  J Shani; A Gazit; T Livshitz; S Biran
Journal:  J Med Chem       Date:  1985-10       Impact factor: 7.446

8.  Modification of the basic side chain in tamoxifen: effects on microsomal metabolism and in vitro biological activity.

Authors:  A B Foster; R McCague; A Seago; G Leclercq; S Stoessel; F Roy
Journal:  Anticancer Drug Des       Date:  1986-11

9.  Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution.

Authors:  K Hamacher; H H Coenen; G Stöcklin
Journal:  J Nucl Med       Date:  1986-02       Impact factor: 10.057

10.  Nonisomerizable analogues of (Z)- and (E)-4-hydroxytamoxifen. Synthesis and endocrinological properties of substituted diphenylbenzocycloheptenes.

Authors:  R McCague; G Leclercq; V C Jordan
Journal:  J Med Chem       Date:  1988-07       Impact factor: 7.446

  10 in total
  1 in total

1.  Synthesis and biological evaluation of novel tamoxifen-1,2,4-triazole conjugates.

Authors:  M S R Murty; Mohana Rao Katiki; Jagadeesh Babu Nanubolu; Srujana Garimella; Sowjanya Polepalli; Nishant Jain; Sudheer Kumar Buddana; R S Prakasham
Journal:  Mol Divers       Date:  2016-06-08       Impact factor: 2.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.